Follow
Louis Maes
Louis Maes
Gewoon Hoogleraar, Universiteit Antwerpen
Verified email at uantwerpen.be
Title
Cited by
Cited by
Year
Anti-infective potential of natural products: How to develop a stronger in vitro ‘proof-of-concept’
P Cos, AJ Vlietinck, DV Berghe, L Maes
Journal of ethnopharmacology 106 (3), 290-302, 2006
18782006
Chagas disease in Latin America: an epidemiological update based on 2010 estimates
O mondiale de la Santé, World Health Organization
Weekly Epidemiological Record= Relevé épidémiologique hebdomadaire 90 (06 …, 2015
1692*2015
Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo
G Brackman, P Cos, L Maes, HJ Nelis, T Coenye
Antimicrobial agents and chemotherapy 55 (6), 2655-2661, 2011
5382011
Leishmania–macrophage interactions: Insights into the redox biology
T Van Assche, M Deschacht, RAI da Luz, L Maes, P Cos
Free Radical Biology and Medicine 51 (2), 337-351, 2011
2822011
In Vitro Susceptibilities of Leishmania donovani Promastigote and Amastigote Stages to Antileishmanial Reference Drugs: Practical Relevance of Stage-Specific …
M Vermeersch, RI da Luz, K Toté, JP Timmermans, P Cos, L Maes
Antimicrobial agents and chemotherapy 53 (9), 3855-3859, 2009
2602009
Open source drug discovery with the malaria box compound collection for neglected diseases and beyond
WC Van Voorhis, JH Adams, R Adelfio, V Ahyong, MH Akabas, P Alano, ...
PLoS pathogens 12 (7), e1005763, 2016
2402016
Advancing drug innovation for neglected diseases—criteria for lead progression
S Nwaka, B Ramirez, R Brun, L Maes, F Douglas, R Ridley
PLoS neglected tropical diseases 3 (8), e440, 2009
1832009
Inhibitory Effect of Biocides on the Viable Masses and Matrices of Staphylococcus aureus and Pseudomonas aeruginosa Biofilms
K Tote, T Horemans, DV Berghe, L Maes, P Cos
Applied and environmental microbiology 76 (10), 3135-3142, 2010
1792010
Biofilms: an extra hurdle for effective antimicrobial therapy
P Cos, K Tote, T Horemans, L Maes
Current pharmaceutical design 16 (20), 2279-2295, 2010
1772010
Synthesis, cytotoxicity, and antiplasmodial and antitrypanosomal activity of new neocryptolepine derivatives
THM Jonckers, S Van Miert, K Cimanga, C Bailly, P Colson, ...
Journal of Medicinal Chemistry 45 (16), 3497-3508, 2002
1752002
A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline
E Davioud-Charvet, S Delarue, C Biot, B Schwöbel, CC Boehme, ...
Journal of medicinal chemistry 44 (24), 4268-4276, 2001
1712001
Plant substances as anti-HIV agents selected according to their putative mechanism of action
P Cos, L Maes, D Vanden Berghe, N Hermans, L Pieters, A Vlietinck
Journal of Natural Products 67 (2), 284-293, 2004
1682004
PLGA nanoparticles and nanosuspensions with amphotericin B: potent in vitro and in vivo alternatives to Fungizone and AmBisome
H Van de Ven, C Paulussen, PB Feijens, A Matheeussen, P Rombaut, ...
Journal of controlled release 161 (3), 795-803, 2012
1632012
Antimalarial, antitrypanosomal, and antileishmanial activities and cytotoxicity of bis (9-amino-6-chloro-2-methoxyacridines): influence of the linker
S Girault, P Grellier, A Berecibar, L Maes, E Mouray, P Lemiere, ...
Journal of medicinal chemistry 43 (14), 2646-2654, 2000
1542000
Synthesis and in Vitro and in Vivo Antimalarial Activity of N-(7-Chloro-4-quinolyl)-1,4-bis(3-aminopropyl)piperazine Derivatives
A Ryckebusch, R Deprez-Poulain, L Maes, MA Debreu-Fontaine, ...
Journal of medicinal chemistry 46 (4), 542-557, 2003
1522003
Extended structure–activity relationship and pharmacokinetic investigation of (4-quinolinoyl) glycyl-2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP)
K Jansen, L Heirbaut, R Verkerk, JD Cheng, J Joossens, P Cos, L Maes, ...
Journal of medicinal chemistry 57 (7), 3053-3074, 2014
1352014
Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent
H Imamura, T Downing, F Van den Broeck, MJ Sanders, S Rijal, S Sundar, ...
Elife 5, e12613, 2016
1342016
Plant-derived leading compounds for chemotherapy of human immunodefiency virus (HIV) infection–an update (1998–2007)
P Cos, L Maes, A Vlietinck, L Pieters
Planta Medica 74 (11), 1323-1337, 2008
1332008
Structure-activity relationship of cinnamaldehyde analogs as inhibitors of AI-2 based quorum sensing and their effect on virulence of Vibrio spp
G Brackman, S Celen, U Hillaert, S Van Calenbergh, P Cos, L Maes, ...
PLoS One 6 (1), e16084, 2011
1292011
Selective inhibitors of fibroblast activation protein (FAP) with a (4-quinolinoyl)-glycyl-2-cyanopyrrolidine scaffold
K Jansen, L Heirbaut, JD Cheng, J Joossens, O Ryabtsova, P Cos, ...
ACS medicinal chemistry letters 4 (5), 491-496, 2013
1192013
The system can't perform the operation now. Try again later.
Articles 1–20